Back to search

University of Patras

Ο ρόλος του εναλλακτικού μονοπατιού του NF-κB στο μη μικροκυτταρικό καρκίνο του πνεύμονα

Abstract

dc:description

The NF-κB family of transcription factors is of paramount importance in cancer. Although, during the last years, research has focused on the classical pathway of NF-ΚB, little is known of the possible role of the alternative pathway, which has just recently been associated with carcinogenesis and solid tumor growth. Notably, the information available on its role in non-small cell lung cancer (NSCLC) is very limited. The aim of the present study was to evaluate the expression of NF-κB2, RELB, NIK and BCL3 (at the mRNA and protein level) in NSCLC and to investigate its association with clinicopathological parameters and overall survival outcome. Furthermore, the clinical significance of 3 NF-κB2 single nucleotide polymorphisms (SNPs) (rs7897947, rs11574852 and rs12769316) and one BCL3 SNP (rs8100239) in NSCLC patients was evaluated. For this purpose, DNA was extracted from 268 blood specimens and paraffin-embedded tissue specimens (adjacent to tumor, non-neoplastic) from patients with NSCLC and 279 blood specimens from healthy donors. Samples were genotyped for the above SNPs using real-time PCR. In a subgroup of the cohort of patients, protein and mRNA expression levels of NF-κB2, RELB, ΝΙΚ and BCL3 were evaluated by immunohistochemistry and quantitative RT-PCR, respectively. The main results of the study can be summarized as follows:1)Protein expression-NF-κB2, RELB, BCL3 and NIK proteins are overexpressed in cancer cells compared to normal adjacent tissues (P<0.001 for all molecules). -NF-κB2, RELB and BCL3 protein expression correlates with the disease stage (P=0.03, P=0.016 and P=0.045, respectively). -Immunopositivity for NF-κB2 and BCL3 correlates with grade (P=0.046 and P=0.002, respectively)-There is a correlation between histological subtype and RELB, NIK and BCL3 protein expression (P=0.008, P=0.002 and P=0.031, respectively). -Lymph node infiltration is associated with NF-κB2 and ΝΙΚ protein expression (P=0.044 και P=0.021).-Two-year survival of patients with NSCLC was related to cytoplasmic expression of RELB (P=0.031). -NF-κB2 protein levels are correlated with RELB protein levels (P=0.029 and P=0.004, respectively).-Smaller in diameter tumors have increased nuclear immunopositivity for BCL3 (P=0.042).-Local relapse rate is correlated with BCL3 and NIK protein expression (P=0.05 and P=0.029)-Cytoplasmic NIK levels are associated with tumor primary site (p=0.032) as well as with BCL3 protein expression levels (p=0.012).2)Gene expression-RELB mRNA levels are elevated in cancer cells compared with normal (P=0.009), while such a difference was not noted for NF-κB2, ΝΙΚ and BCL3. -mRNA expression of NF-κB2, RELB and BCL3 is associated with the histological subtype (P=0.031, P=0.022 and P=0.021, respectively) and maximum diameter of the tumor (P=0.046, P=0.028 and P=0.026, respectively). NF-κB2 mRNA levels are related to grade (P=0.016), while RELB mRNA levels are associated with relapse rates (P=0.005).3)Single nucleotide polymorphisms-Rs12769316 SNP (NF-κB2) was found to be associated with NSCLC risk and patients’ survival. In particular, genotype AA (rs12769316G>A) was correlated with NSCLC risk (P=0.003), while a trend was observed between allele A (rs12769316) carriage and three-year survival of stage I patients (P=0.057). On the contrary, stage II homozygotes GG (rs12769316) had poorer survival compared to A allele carriers (P=0.012). In addition, rs12769316 was correlated with NF-κB2 protein expression (P=0.001), disease stage (P=0.042) and with the maximum diameter of tumors (P=0.025).-Allele distribution of the NF-κB2 SNP rs7897947 differs between patients and healthy donors (P=0.024) and is related to disease stage and tumor size (P=0.016 και P=0.04 respectively). - The NF-κB2 SNP rs11574852 was associated with relapse rate (P=0.045), histological subtype, grade, 2-year survival (P=0.036, P=0.004 and P=0.05 respectively) and NF-κB2 protein expression (P<0.001).- The BCL3 SNP rs8100239 was associated with 2-year survival regardless of disease stage (P=0.009). Conclusively, the above findings support the deregulation of the alternative pathway of NF-κB in NSCLC, implicating this signalling pathway in carcinogenesis and tumor growth. Furthermore, it seems that genetic markers of this pathway are associated with NSCLC, though more studies are needed to elucidate their role and significance.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2015

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Dimitrakopoulos, Foteinos-Ioannis
  • Δημητρακόπουλος, Φωτεινός-Ιωάννης

Subjects

dc:subject × 9

Rights

dc:rights
Statement dc:rights
  • BY_NC_ND
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/36030

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Dimitrakopoulos, Foteinos-Ioannis; Δημητρακόπουλος, Φωτεινός-Ιωάννης. Ο ρόλος του εναλλακτικού μονοπατιού του NF-κB στο μη μικροκυτταρικό καρκίνο του πνεύμονα. University of Patras, 2015. http://hdl.handle.net/10442/hedi/36030